What you need to know:
- Vaccine-preventable diseases include but are not limited to measles, polio, whooping cough, tetanus, diphtheria, meningitis, yellow fever, hepatitis B, tuberculosis, pneumonia, diarrhoea and cervical cancers.
- Among these diseases, measles remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine.
It is estimated that about three million children under five years of age die each year in the African Region and a significant number of these deaths could be prevented by vaccines.
Yet one in five children does not receive them. Lack of service delivery in remote areas or lack of information about the effectiveness of vaccines is a major reason many do not receive them.
“Countries and stakeholders must raise the visibility of vaccine-preventable diseases, address barriers to vaccination, and make substantial and sustained additional investments to strengthen health systems and achieve equitable access to immunisation services,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.
Vaccine-preventable diseases include but are not limited to measles, polio, whooping cough, tetanus, diphtheria, meningitis, yellow fever, hepatitis B, tuberculosis, pneumonia, diarrhoea and cervical cancers.
Among these diseases, measles remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine.
Measles is estimated to have caused 145700 deaths globally in 2013, of which it is estimated that 38 000 were in the countries within the WHO African Region. It is a highly contagious, serious disease caused by a virus. In 1980, before widespread vaccination, measles caused an estimated 2.6 million deaths each year.
In 2013, the WHO/ UNICEF coverage estimates indicate that 74% of children in the Region have received one dose of measles vaccine by their first birthday, up from 53 per cent in 2000.
Since 2001, more than 750 million children have been vaccinated in the African Region against measles through supplemental mass vaccination campaigns.
Measles-related deaths are caused by complications associated with the disease. Complications include severe diarrhoea and related dehydration, severe respiratory infections such as pneumonia, blindness, encephalitis (an infection that causes brain swelling). Measles can also trigger severe malnutrition or disseminated tuberculosis infections.
Severe measles is more likely among poorly nourished young children, especially those with insufficient vitamin A, or whose immune systems have been weakened by HIV/AIDS or other diseases. In populations with high levels of malnutrition and a lack of adequate health care, up to 10% of measles cases result in death.
Measles outbreaks can be particularly deadly in countries experiencing or recovering from natural disasters, conflicts or weaknesses in health systems.
In countries where measles has been largely eliminated, cases imported from other countries remain an important source of infection. The highly contagious virus is spread by coughing and sneezing, close personal contact or direct contact with infected nasal or throat secretions.
The first sign of measles is usually a high fever, which begins about 10 to 12 days after exposure to the virus, and lasts four to seven days.
A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage.
After several days, a rash erupts, usually on the face and upper neck. Over about three days, the rash spreads, eventually reaching the hands and feet.
Severe complications from measles can be avoided through supportive care that ensures good nutrition, adequate fluid intake, vitamin A supplementation and treatment of diarrhoea with WHO-recommended oral rehydration solution and zinc.
This solution replaces fluids and other essential elements that are lost through diarrhoea or vomiting.
Antibiotics should be prescribed to treat eye and ear infections, and pneumonia. WHO recommends reaching all children with two doses of measles vaccine as the standard for all national immunisation programmes.
In countries with ongoing measles transmission, the first dose of measles vaccine is recommended to be administered at nine months of age and the second between 15 – 18 months of age.
This year African countries are gearing up to commemorate the 5th African Vaccination Week (AVW) which will be observed throughout the region from April 24 to April 30 under the theme “Vaccination, a gift for life”.
The theme draws attention to the importance of ensuring that every one particularly children are immunised against vaccine-preventable diseases.